Page last updated: 2024-08-24

gemcitabine and deuterium oxide

gemcitabine has been researched along with deuterium oxide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alken, RG; Bader, Y; Fritzer-Szekeres, M; Grusch, M; Hartmann, J; Heller, N; Horvath, Z; Krupitza, G; Madlener, S; Maier, S; Oehler, L; Saiko, P; Szekeres, T	1

Other Studies

1 other study(ies) available for gemcitabine and deuterium oxide

Article	Year
Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines. Cancer letters, 2008, Feb-08, Volume: 259, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Marrow Cells; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; Deuterium Oxide; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Hematopoietic Stem Cells; Humans; Inhibitory Concentration 50; Neoplastic Stem Cells; Pancreatic Neoplasms; Tumor Stem Cell Assay	2008

Article

Year

Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.

Cancer letters, 2008, Feb-08, Volume: 259, Issue:2

Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Marrow Cells; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; Deuterium Oxide; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Hematopoietic Stem Cells; Humans; Inhibitory Concentration 50; Neoplastic Stem Cells; Pancreatic Neoplasms; Tumor Stem Cell Assay

2008